Abstract
Aim:
To investigate whether the amlodipine derivatives, CJX1 and CJX2, have a modulative effect on P-glycoprotein (P-gp) function in rat brain microvessel endothelial cells (RBMEC).
Methods:
Isolated RBMEC were cultured in DMEM/F12 (1:1) medium. The amount of intracellular rhodamine (Rh123) was determined, using a fluorescence spectrophotometer, to evaluate the function of P-gp.
Results:
The accumulation of Rh123 in RBMEC was potentiated in a concentration dependent manner after incubation with CJX1 and CJX2 at 1, 2.5, 5, and 10 μmol/L (P<0.01), but no accumulation of Rh123 was observed in human umbilical vein endothelial cells after incubation with CJX1 and CJX2 10 μmol/L (P>0.05). Accumulation of intracellular Rh123 was increased and efflux of intracellular Rh123 was decreased in a time-dependent manner from 0–100 min after CJX1 and CXJ2 at 10 μmol/L treatment. The inhibitory effect of CJX1 and CJX2 on P-gp function was reversible and remained even at 120 min after removal of CJX1 and CJX2 at 2.5 μmol/L from the medium.
Conclusion:
CJX1 and CJX2 exhibited a potent effect in the inhibition of P-gp function in vitro.
Similar content being viewed by others
Article PDF
References
Germann UA . P-glycoprotein-a mediator of multidrug resistance in tumour cells. Eur J Cancer 1996; 32A: 927–44.
Gottesman MM, Pastan I . Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385–427.
Childs S, Ling V . The MDR superfamily of genes and its biological implications. Important Adv Oncol 1994; 21–36.
Elsinga PH, Hendrikse NH, Bart J, Vaalburg W, van Waarde A . PET studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS. Curr Pharm Des 2004; 10: 1493–503.
Cisternino S, Rousselle C, Debray M, Scherrmann JM . In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier. Pharm Res 2003; 20: 1607–11.
Zhao YL, Du J, Kanazawa H, Sugawara A, Takagi K, Kitaichi K, et al. Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice. Eur J Pharmacol 2002; 445: 115–23.
Sakata A, Tamai I, Kawazu K, Deguchi Y, Ohnishi T, Saheki A, et al. In vivo evidence for ATP-dependent and P-glycoprotein- mediated transport of cyclosporin A at the blood-brain barrier. Biochem Pharmacol 1994; 48: 1989–92.
Twentyman PR . Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins. Br J Cancer 1988; 57: 254–8.
Aszalos A, Thompson K, Yin JJ, Ross DD . Combinations of P-glyco-protein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp). Anticancer Res 1999; 19: 1053–64.
Ohbayashi Y, Tsutamoto T, Sakaguchi T, Tanaka T, Kanamori T, Yokohama H, et al. Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine. J Cardiovasc Pharmacol 2003; 42 Suppl 1: S71–4.
Katoh M, Nakajima, M, Yamazaki H, Yokoi T . Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4. Pharm Res 2000; 17: 1189–97.
Abbott NJ, Hughes CC, Revest PA, Greenwood J . Development and characterization of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci 1992; 103: 23–37.
Fontaine M, Elmquist WF, Miller DW . Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sci 1996; 59: 1521–31.
Sarver JG, Klis WA, Byers JP, Erhardt PW . Microplate screening of the differential effects of test agents on Hoechst 33342, rhodamine 123, and rhodamine 6G accumulation in breast cancer cells that overexpress P-glycoprotein. J Biomol Screen 2002; 7: 29–34.
Beaulieu E, Demeule M, Ghitescu L, Beliveau R . P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem J 1997; 326 (Pt 2): 539–44.
Zhu HJ, Liu GQ . Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells. Acta Pharmacol Sin 2003; 24: 1143–9.
He L, Liu GQ . Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. Acta Pharmacol Sin 2002; 23: 591–6.
Green LJ, Marder P, Slapak CA . Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells. Biochem Pharmacol 2001; 61: 1393–9.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by Natural Science Foundation of Jiangsu Province (No BK2004110).
Rights and permissions
About this article
Cite this article
Ji, Bs., He, L. & Liu, Gq. Modulation of P-glycoprotein function by amlodipine derivatives in brain microvessel endothelial cells of rats. Acta Pharmacol Sin 26, 166–170 (2005). https://doi.org/10.1111/j.1745-7254.2005.00528.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00528.x